Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01120808 · ClinicalTrials.gov registry record · Phase 1
Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED)
A Phase 1 study of Blister, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 136
- Enrollment target
- 2
- Study locations
NCT01120808: Completed Phase 1 study of Blister, sponsored by Stanford University.
NCT01120808 is a Phase 1 study of Blister that has completed, run by Stanford University. The registered enrollment target is 136 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (127% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01120808, a Phase 1 study of Blister, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 136 participants
- Enrollment target
- 2
- Study locations
Study Summary
Blisters are a very common complaint in both the general population and also the athlete. This study's aim is to determine whether applying paper tape (an inexpensive and common component of most foot care kits) to the foot of endurance runners prevents the frequency and severity of friction blisters.
Conditions Studied
Interventions
- PROCEDURE Paper tape
Study Locations (2)
California
- University of California Davis - Davis
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
What the finished NCT01120808 record still lists
NCT01120808 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (127% higher).
The record links to 1 condition, with Blister appearing as the primary indexed condition, and to 1 intervention - of which Paper tape is the first listed.
NCT01120808 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01120808 about?
NCT01120808 is a clinical study titled "Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED)". Blisters are a very common complaint in both the general population and also the athlete. This study's aim is to determine whether applying paper tape (an inexpensive and common component of most foot care kits) to the foot of endurance runners prevents the frequency and severity of friction blister...
What is the current status of trial NCT01120808?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 136 participants. The study started on 2010-04. Estimated completion is 2011-12.
What conditions does trial NCT01120808 study?
This clinical trial studies the following conditions: Blister.
What interventions are being tested in trial NCT01120808?
The interventions under investigation include: Paper tape (PROCEDURE).
Who is sponsoring clinical trial NCT01120808?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01120808 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blister
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01120808's enrollment target sits among peer trials
136 422nd of 2000 higher than 1,576 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia